Recro to Present at Stephens Annual Investment Conference
02 December 2021 - 11:00PM
Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract
development and manufacturing organization (CDMO) dedicated to
solving complex formulation and manufacturing challenges primarily
in small molecule therapeutic development, today announced that its
chief executive officer, David Enloe, will participate in a
fireside chat as part of the Stephens Annual Investment Conference
| NASH2021. Details for the fireside chat are as follows:
-
Stephens Annual Investment Conference | NASH2021
-
Conference dates: December 1 - 3, 2021
-
Presentation details: Recro management will
participate in a fireside chat on Friday, December 3, 2021 at 11:00
– 11:45am CT/12:00 – 12:45pm ET. The company will also host 1-on-1
meetings with investors on Friday, December 3, 2021
-
Location: Omni Nashville Hotel, Nashville, TN
-
Webcast: A live audio webcast of the fireside chat
will be available under "Events" in the Investors section of the
company's website, https://ir.recropharma.com/events. An archived
webcast will be available on the company's website approximately
two hours after the event and will be available for 30 days.
About Recro
Recro (NASD: REPH) is a bi-coastal contract
development and manufacturing organization (CDMO) with capabilities
spanning pre-Investigational New Drug (IND) development to
commercial manufacturing and packaging for a wide range of
therapeutic dosage forms with a primary focus in the area of small
molecules. With an expertise in solving complex manufacturing
problems, Recro is a leading CDMO providing therapeutic
development, end-to-end regulatory support, clinical and commercial
manufacturing, aseptic fill/finish, lyophilization, packaging and
logistics services to the global pharmaceutical market.
In addition to our experience in handling DEA
controlled substances and developing and manufacturing
modified-release dosage forms, Recro has the expertise to deliver
on our clients’ pharmaceutical development and manufacturing
projects, regardless of complexity level. We do all of this in our
best-in-class facilities, which total 145,000 square feet, in
Gainesville, Georgia and San Diego, California.
For more information about Recro’s CDMO
solutions, visit recrocdmo.com.
Contacts
Stephanie Diaz (Investors)
Vida Strategic Partners
(415) 675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
(415) 675-7402
tbrons@vidasp.com
Ryan D. Lake (CFO)
Recro
(770) 531-8365
ryan.lake@recroCDMO.com
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From Jan 2025 to Feb 2025
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From Feb 2024 to Feb 2025
Real-Time news about Recro Pharma Inc (NASDAQ): 0 recent articles
More News Articles